A Team of Global Leaders in Molecular Profiling and Bioinformatics

It takes a team of experts in personalized health, systems biology, computing sciences, data visualization and design to understand and deliver the vast amounts of molecular data and compare it with the latest scientific literature and clinical advances. Molecular You brings together global leaders in their respective fields to interpret this data and turn it into useable information that can be acted upon.

Robert Fraser, PhD,
Chief Executive Officer

Rob is the co-founder of The Personalized Medicine Initiative (PMI), and has been at the forefront of developing the framework and technologies to bring personalized medicine into healthcare practice. Backed by his expertise in molecular diagnostics, molecularly targeted drug discovery and development, biochemistry and regulatory compliance, Rob has also been involved in leading drug discovery and development projects at Sanofi, Xenon, Neuromed and CDRD.  Rob received extensive training in the molecular mechanisms of endocrinology while completing his Ph.D. at the University of Alberta and Harvard Medical School and Post-Doctoral Fellowships at Hospital for Sick Children, Toronto and IGBMC, Strasbourg France. In addition to Rob’s scientific accomplishments, he has been involved in the raising of more than $37M in funding. Rob is also co-founder of GenXys Health Care Systems, Personalized Biomarkers Incorporated, Mesentech Corporation and Novobind.

David Wishart, PhD,
Chief Informatics officer

David holds a Ph.D. from Yale (1991) and is a Professor in the Departments of Biological Sciences and Computing Science at the University of Alberta. He is also a senior research officer and the director of the Nano Life Science program at the Canadian National Research Council’s National Institute for Nanotechnology. From 2006-2009, David led the “Human Metabolome Project” (HMP), a multi-university, multi-investigator project that catalogued all of the known metabolites in human tissues and bio-fluids. Using advanced methods David and his colleagues identified or found evidence for more than 8500 endogenous metabolites. The methods and ideas developed for the HMP have helped lay the foundation for a number of clinical metabolomics projects currently being pursued in his lab. David has published more than 40 papers in the field of metabolomics and currently directs the Metabolomics Innovation Centre.

Christoph Borchers, PhD, Chief Technology Officer

Christoph is recognized as a pioneer and leading figure in the development of mass spec based methods for protein quantification using Multiple Reaction Monitoring (MRM). He is also the Director of the UVic–Genome BC Proteomics Centre and has published more than 180 peer-reviewed papers in scientific journals. His research is centered around the improvement, development and application of proteomics technologies with a major focus on techniques for quantitative targeted proteomics for clinical diagnostics. Christoph received his B.S., M.Sc. and Ph.D. from the University of Konstanz, Germany. After his post-doctoral training and employment as a staff scientist at NIEHS/NIH/RTP, NC and he was the director of the Duke-UNC Proteomics Facility and held a faculty position at UNC Medical School in Chapel Hill, NC (2001-2006). Christoph is also involved in promoting proteomics research and education through his involvement with HUPO (International Council Member), the British Columbia Proteomics Network (co-leader) and the Canadian National Proteomics Network (VP External, Chair of the Board of Directors).

Dan Nixon, MBA
Chief Financial Officer

Dan holds an MBA from the University of Western Ontario and Bachelor of Commerce degree from the University of Calgary. Dan was co-founding Director and CFO of Midlake Oil & Gas Limited and prior to that, Senior Vice President and Managing Director, Private Equity at MDS Capital Corp., a life science-focused venture capital company with more than $1.2 billion under management. Before MDS, Dan was Senior Vice President, Finance at Kinetek Pharmaceuticals and CFO at Inex Pharmaceuticals. In addition, Dan was Vice President, Corporate Finance and Manager of Private Equity at Burns Fry Limited (now BMO Nesbitt Burns) and Vice President of Canadian Enterprise Development Corporation. Dan has held many directorships in companies across Canada and the United States, and currently holds directorships at Precision NanoSystems Inc. and AllerGen NCE.

Victoria Lemieux, PhD,
Chief Information Security Officer

Victoria is an Associate Professor of Archival Studies at the University of British Columbia in Vancouver, Canada. She has held senior positions as a professional archivist and records manager within the public sector, as a VP responsible for information governance and IT Security for a global investment bank, in higher education as an senior administrator and educator, and at the World Bank as a Senior Public Sector Specialist. She has also consulted for the United Nations, the Commonwealth Secretariat, and the Inter-American Development Bank and has collaborated on research projects with the US Treasury, Office of Financial Research. Her current research is focused on risk to the availability of trustworthy records, in particular in financial contexts, and how these risks impact upon transparency, financial stability, public accountability and human rights. Dr. Lemieux currently sits on the International Standards Organization’s Canadian Mirror Committees for Technical Committee 68 (financial services) and 307 (blockchains and distribution ledgers). She holds a doctorate from University College London (Archival Studies, 2002), which focused on the information-related causes of the Jamaican Banking Crisis and, since 2005, has been a Certified Information Systems Security Professional (CISSP). She is also the winner of the 2015 Emmett Leahy Award for outstanding contributions to the field of records management and a 2015 World Bank Big Data Innovation Award. She is the author and editor of award winning articles and books, including Financial Analysis and Risk Management: Data Governance, Analytics and Life Cycle Management (Springer, 2012) and Building Trust in Information – Perspectives on the Frontiers of Provenance (Springer, 2016).

Mike Edwards,
VP, Sales & Strategic Partnerships

Mike is an accomplished, client-driven Senior Sales and Marketing Executive offering over 36 years of progressive experience including start-ups across numerous product and services. He brings to Molecular You strong people management and a background in branch operations, client relationships and implementing creative sales strategies. He is a well-established sales professional with the ability to secure strategic alliances by effective communication with top “C Level” business executives. Throughout his career, Mike has achieved solid revenue, market share and profit contributions through staff development, market planning, finance and profitability responsibilities.

Haiyan Yang PhD, MBA,
VP, Operations

Haiyan has over 18 years of research management experience with broad expertise in the R&D of new pharmaceutical drugs and molecular diagnostics. She has a strong entrepreneurial spirit and is actively facilitating business collaborations in personalized health technology and services between Canada and China. Haiyan earned her PhD in molecular biology from the University of Victoria and completed her postdoc at the National Cancer Institute in the United States. She later joined Inimex and Migenix as an R&D scientist, developing new pharmaceutical drugs. After earning her MBA degree from Simon Fraser University, Haiyan held leadership roles in the Facility for Infectious Disease and Epidemic Research at UBC, one of the largest containment level 3 facilities in Canada. Haiyan brings extensive experience in research and development, operations management, regulatory compliance and business development to Molecular You.